Genotyping of enteroviruses isolated in Kenya from pediatric patients using partial VP1 region by unknown
Opanda et al. SpringerPlus  (2016) 5:158 
DOI 10.1186/s40064-016-1834-0
RESEARCH
Genotyping of enteroviruses isolated 
in Kenya from pediatric patients using partial 
VP1 region
Silvanos M. Opanda1,4, Fred Wamunyokoli3, Samoel Khamadi2, Rodney Coldren1 and Wallace D. Bulimo1,5*
Abstract 
Enteroviruses (EV) are responsible for a wide range of clinical diseases in humans. Though studied broadly in sev-
eral regions of the world, the genetic diversity of human enteroviruses (HEV) circulating in the sub-Saharan Africa 
remains under-documented. In the current study, we molecularly typed 61 HEV strains isolated in Kenya between 
2008 and 2011 targeting the 3′-end of the VP1 gene. Viral RNA was extracted from the archived isolates and part 
of the VP1 gene amplified by RT-PCR, followed by sequence analysis. Twenty-two different EV types were detected. 
Majority (72.0 %) of these belonged to Enterovirus B species followed by Enterovirus D (21.3 %) and Enterovirus A 
(6.5 %). The most frequently detected types were Enterovirus-D68 (EV-D68), followed by Coxsackievirus B2 (CV-B2), 
CV-B1, CV-B4 and CV-B3. Phylogenetic analyses of these viruses revealed that Kenyan CV-B1 isolates were segregated 
among sequences of global CV-B1 strains. Conversely, the Kenyan CV-B2, CV-B3, CV-B4 and EV-D68 strains generally 
grouped together with those detected from other countries. Notably, the Kenyan EV-D68 strains largely clustered 
with sequences of global strains obtained between 2008 and 2010 than those circulating in recent years. Overall, our 
results indicate that HEV strains belonging to Enterovirus D and Enterovirus B species pre-dominantly circulated and 
played a significant role in pediatric respiratory infection in Kenya, during the study period. The Kenyan CV-B1 strains 
were genetically divergent from those circulating in other countries. Phylogenetic clustering of Kenyan EV-D68 strains 
with sequences of global strains circulating between 2008 and 2010 than those obtained in recent years suggests a 
high genomic variability associated with the surface protein encoding VP1 gene in these enteroviruses.
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Background
Enteroviruses (EV), family Picornaviridae and genus 
Enterovirus, are common etiologic agents of diseases 
affecting millions of people worldwide every year 
(Jacques et  al. 2008; Oberste et  al. 2003). The disease 
manifestations range from asymptomatic to a wide 
variety of acute diseases, including mild respiratory ill-
nesses, hand, foot and mouth disease, aseptic meningi-
tis, encephalitis, myocarditis, and neonatal sepsis-like 
diseases (Tan et al. 2011; Khetsuriani et al. 2006; Kiang 
et  al. 2009; Harvala et  al. 2014; Chiang et  al. 2012; 
Linsuwanon et  al. 2012; Kumar et  al. 2013). They are 
classified into twelve species based on molecular char-
acteristics and biological properties (Kumar et al. 2013; 
Nasri et  al. 2007; Hu et  al. 2011; Pallansch and Roos 
2007). Seven of these species, namely Enterovirus A, 
Enterovirus B, Enterovirus C, Enterovirus D, Rhino-
virus A, B and C affect humans (Adams et  al. 2014, 
2015). Enterovirus A species comprises Coxsackievirus 
A2 (CV-A2), CV-A3, CV-A4, CV-A5, CV-A6, CV-A7, 
CV-A8, CV-A10, CV-A12, CV-A14, CV-A16, enterovi-
rus A71 (EV-A71), EV-A76, EV-A89, EV-A90, EV-A91, 
EV-A92, EV-A114, EV-A119, EV-A120 and EV-A121 
(Oberste et al. 2004, 2005; Pöyry et al. 1994; Brown and 
Pallansch 1995; Adams et  al. 2013; King et  al. 2012). 
Enterovirus B species includes Coxsackievirus B1 (CV-
B1), CV-B2, CV-B3, CV-B4, CV-B5, CV-B6, CV-A9, all 
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echoviruses, enterovirus B69 (EV-B69), EV-B73, EV-B74, 
EV-B75, and EV-B77-107 (Adams et al. 2013; King et al. 
2012). Enterovirus C members include Coxsackievi-
rus A1 (CV-A1), CV-A11, CV-A13, CV-A17, CV-A19, 
CV-A20, CV-A21, CV-A22, CV-A24, EV-C95, EV-C96, 
EV-C99, EV-C102, EV-C104, EV-C105, EV-C109, 
EV-C113, EV-C116, EV-C117, EV-C118 and Polioviruses 
(PV1-3) (Adams et al. 2013; King et al. 2012; Brown et al. 
2003) while Enterovirus D comprises Enterovirus D68 
(EV-D68), EV-D70, EV-D94 and EV-D111 types (Adams 
et al. 2013; King et al. 2012). To date, over 100 antigeni-
cally distinct human enterovirus (HEV) types have been 
described (Chiang et al. 2012).
The conventional method for typing EV is by isola-
tion in cell culture followed by neutralization tests 
using pooled antisera (Kiang et  al. 2009; Nasri et  al. 
2007). However, neutralization assays are labor-
intensive and often result in untypeable strains (Chi-
ang et al. 2012; Nasri et al. 2007). Presently, typing of 
EV is often based on reverse transcription-PCR fol-
lowed by sequencing (Kumar et  al. 2013; Nasri et  al. 
2007; Perera et  al. 2010; Tan et  al. 2011; Casas et  al. 
2001; Nix et  al. 2006; Kroneman et  al. 2011). Differ-
ent genomic regions, especially those encoding viral 
structural proteins are usually targeted (Perera et  al. 
2010). The enterovirus genome is approximately 7.5 kb 
and is composed of a single open reading frame (ORF) 
flanked by 5′ and 3′ untranslated regions (UTRs) (Hu 
et  al. 2014; Solomon et  al. 2010). The ORF encodes a 
single polyprotein that is cleaved by viral proteases to 
yield structural proteins VP1–VP4 and non-structural 
proteins 2A, 2B, 2C, 3A, 3B, 3C and 3D (Hu et al. 2014; 
Solomon et  al. 2010). Among the structural proteins, 
the VP1 is the major surface-accessible viral capsid 
and contains a type-specific antigenic neutralization 
site, the BC-loop (Reimann et  al. 1991; Norder et  al. 
2003). Genotyping of enteroviruses based on the VP1 
gene has been shown to correlate well with those made 
by antigenic properties (Oberste et  al. 1999, 2003; 
Nasri et al. 2007; Pallansch and Roos 2007).
Typing of EV is essential as it can provide vital infor-
mation for establishment of temporal patterns of circu-
lation of different types, detection of newly emerging or 
unidentified types, guidance to outbreak investigation 
and disease association studies, guidance to develop-
ment of new diagnostics/therapies, and augmentation 
of poliomyelitis surveillance (Khetsuriani et  al. 2006; 
Chiang et al. 2012; Kumar et al. 2013; Nasri et al. 2007). 
Here, we report on the diversity of HEV types isolated 
in a pediatric population in Kenya between 2008 and 
2011 by sequencing a portion of the VP1 gene.
Methods
Study sites, inclusion criteria, clinical parameters and virus 
isolation
The HEV isolates (n = 200) used in this study were first 
propagated in culture and presence of the virus con-
firmed by indirect fluorescent antibody (IDFA) test using 
Amplifluor® ID Pan-Enterovirus Detection Kit (Milli-
pore Corporation, USA) according to the manufacturer’s 
instructions. They were retrieved from archives of the 
respiratory virus surveillance program in the Depart-
ment of Emerging Infectious Diseases (DEID) of the 
United States Army Medical Research Directorate-Kenya 
in collaboration with the Kenya Medical Research Insti-
tute (KEMRI). The program surveillance network was 
selected to include disparate geographic regions and 
population demographics across the country. The inclu-
sion criteria consisted of being an outpatient, ≥2 months 
of age, and having influenza-like-illness (ILI) symptoms 
as defined by the WHO Global Surveillance Manual 
on Influenza (WHO 2012). Demographic information 
including age, sex, occupation, and workplace and resi-
dence history were ascertained for all participants. Clini-
cal parameters and symptoms including recent history 
of ILI, cough, difficulty in breathing, chills, sore throat, 
muscle aches, retro-orbital pain, malaise, vomiting, neu-
rological symptoms, abdominal pain, nasal stuffiness, 
runny nose, sputum production, headache, joint pain, 
fatigue, diarrhea, and bleeding were documented. Naso-
pharyngeal specimens were collected and viruses isolated 
using rhabdomyosarcoma (RD) cells (ATCC® CCL-136™) 
prepared in culture tubes (Nunc, Denmark). Each cul-
ture tube containing RD cells in Dulbecco’s minimum 
essential medium (Life Technologies, USA) was infected 
with 100 µl of specimen and incubated at 33 °C with 5 % 
CO2 until the appearance of cytopathic effects (CPEs) or 
14 days post-infection with no observable CPEs.
Ethics statement
The study objectives were verbally explained to the par-
ents/guardians/next of kin and consent obtained before 
sample collection. After verbal explanation of the objec-
tives by study personnel, the parents/guardians/next of 
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kin were given time to read and understand the question-
naire in a language they understood. Then, the parent/
guardian/next of kin was presented with duplicate writ-
ten informed consent forms allowing for collection and 
testing of a specimen. An independent and trusted wit-
ness read the consent forms for those who were illiterate. 
The witness guided them through the consent process 
and in appending their signatures/thumbprint on the 
consent form. Patients were allowed to withdraw consent 
at any point during the study. Of the duplicate copies, the 
first copy was retained by the patient/guardian and the 
other copy was kept on record for regulatory review. Two 
ethical review boards, the Walter Reed Army Institute of 
Research (WRAIR) Institutional Review Board (IRB) and 
the Kenya Medical Research Institute (KEMRI) Ethics 
Review Committee (ERC), approved this study and con-
sent procedure under protocol approvals WRAIR#1991 
and KEMRI SSC#2383 respectively.
Partial VP1 reverse transcription‑PCR and sequencing
Viral RNA was extracted from infected culture superna-
tants with a QIAamp Viral Mini Kit (Qiagen, Inc., USA), 
according to the manufacturer’s instructions. Partial VP1 
gene (3′-end of VP1 gene) was amplified by RT-PCR 
using primers 292 (5′-MIGCIGYIGARACNGG-3′, posi-
tion: 2612–2627) and 222 (5′-CICCIGGIGGIAYRWA-
CAT-3′, position: 2969–2951) as previously described 
(Oberste et al. 2006; Vignuzzi et al. 2005). PCR amplicons 
(~350  bp) were analyzed by electrophoresis using 1.0  % 
Agarose gels (Sigma-Aldrich Co., USA), stained in ethid-
ium bromide (0.5 μg/ml) and visualized using the Alpha 
Imager (Alpha Innotech, USA). Amplicons were puri-
fied using Exonuclease I/Shrimp Alkaline Phosphatase 
(ExoSap-IT) enzyme (Affymetrix, USA) and sequenced 
directly in both directions using the RT-PCR primers. 
Sequencing was performed using Big Dye Terminator 
Cycle sequencing kit v3.1 (Applied Biosystems, USA) and 
analyzed using the automated 3500xL Genetic Analyzer 
(Applied Biosystems, USA) according to the manufactur-
er’s instructions.
Sequence analysis
VP1 DNA nucleotide sequence fragments were edited 
and assembled into Contigs (~350 nucleotides) using 
DNA baser version 3.2 (2012). Type identity of the iso-
lates was determined by homology analysis, using CLC 
genomics Workbench v6.5 software (CLC bio, Den-
mark). An isolate was determined to be homologous to 
a prototype strain if it shared ≥75 % nucleotide identity 
(≥85  % amino acid similarity) with the reference strain 
(Oberste et al. 2003). Multiple sequence alignments were 
performed by Muscle v3.8 software (Edgar 2004). Phy-
logenetic analyses based on nucleotide sequences of the 
VP1 region were carried out using MrBayes v3.2 software 
and MEGA 6.0 program (Ronquist et  al. 2012; Tamura 
et al. 2013). The Bayesian trees generated were visualized 
using Fig Tree v1.4.0 software (Rambaut 2009).
GenBank accession numbers
Nucleotide sequences of the partial VP1 gene of EV iso-
lates reported in this study are available in the GenBank 
under accession numbers: KJ472833 to KJ472893.
Prototype strains
The EV prototype strains whose VP1 nucleotide 
sequences were used in this study were retrieved from the 
GenBank database under accession numbers: AB426608 
to AB426609; AJ493062; AY036579; AY208120; 
AY421760 to AY421769; AY302539 to AY302556; 
AY302560; AY426531; AY556057; AY556070; AY697458 
to AY697461; AY919484; AF029859; AF039205; 
AF081311; AF081485; AF083069; AF114383; AF162711; 
AF241359; AF317694; AF499635 to AF499637; 
AF499639; AF499641 to AF499643; AF546702; EF555644 
to EF555645; AY843297 to AY843299; AY843300; 
AY843301; AY843303-AY843308; D00627; DQ201177; 
DQ902712; DQ916377; EF127244; EF015886; EU840733; 
GQ865517; JQ446368; JQ768163; JX514942-JX514943; 
JX417822; K01392; KC787153; KF312882; KF385945; 
M12197; M16560; M88483; U05876; U22521; V01149; 
X05690; X79047; X80059; X84981 (source: http://www.
picornaviridae.com/enterovirus/enterovirus.htm).
Results
Overall, 187 (93.5 %) of the archived isolates propagated 
in culture were confirmed positive for EV by IDFA. Of 
these, 124 (66.3  %) RNA extracts amplified successfully 
by RT-PCR. Upon nucleotide sequencing, 85 (68.5  %) 
RT-PCR amplicons yielded clean and readable sequences. 
Preliminary BLASTn search analyses revealed that 61 
were Enterovirus species while 24 were Rhinoviruses. 
Among the patients from whom enterovirus amplicons 
were detected; 35 (57.4 %) were males while 26 (42.6 %) 
females, giving a gender ratio of 1.4:1. The age of patients 
ranged from 2 months to 7 years. Infections were more 
common in children aged <3 years (40/61, 65.6 %) than 
those aged ≥3  years (34.4  %). The most common clini-
cal manifestations included cough (100.0  %), runny 
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nose (91.8 %) and stuffy nose (47.5 %). Other symptoms 
included vomiting (29.5  %), malaise (27.9  %), fatigue 
(23.0  %), chills (21.3  %), diarrhea (19.7  %), difficulty in 
breathing (16.4  %), headache (11.5  %), abdominal pain 
(11.5  %) and sore throat, neurological conditions and 
joint pains (<1.0 %).
Homology analyses based on 3′-end of the VP1 gene 
showed that majority of EV types detected in Kenya 
(except echovirus 11 strain; GeneBank accession num-
ber KJ472870) shared ≥75.0  % (nucleotide) or ≥85.0  % 
amino acid sequence identities with homotypic proto-
type strains (Table  1). The Kenyan echovirus 11 isolate 
exhibited a slightly lower nucleotide sequence identity 
(74.02  %) when compared to echovirus-11 prototype 
strain (Gregory) but higher nucleotide sequence iden-
tities (89–90  %) with recently isolated echovirus-11 
strains with GenBank accession numbers GU393825 
and JQ744302, respectively. Majority of the Kenyan iso-
lates belonged to Enterovirus B species (n = 44) followed 
by Enterovirus D (n  =  13) and Enterovirus A (n  =  4). 
None of the isolates belonged to Enterovirus C species 
(Table 1). Confirmation of type identities assigned to the 
isolates by pair-wise alignment obtained using phylog-
eny of the Kenyan isolates and those of HEV prototype 
strains revealed separation of the sequences into four 
distinct groups, delineating Enterovirus A, Enterovi-
rus B, Enterovirus C and Enterovirus D species (Fig. 1). 
All the Kenyan isolates clustered closely with respec-
tive homotypic prototypes, supported by high posterior 
probability nodal values of 80.0–100.0  %. Majority of 
the isolates (n  =  44) clustered with Enterovirus B spe-
cies prototype strains followed by Enterovirus D (n = 13) 
and Enterovirus A (n = 4) (Fig. 1). These results corrobo-
rated those determined by homology analysis. Moreover, 
phylogenetic analyses of the most frequently detected 
EV types with sequences of homotypic reference strains 
sampled from GenBank revealed segregation of Kenyan 
CV-B1 isolates from the global strains used in the study 
(Fig.  2). The Kenyan CV-B2 strains were closely related 
to those isolated in countries such as Australia (2006), 
the United Kingdom (2008) and India (2010–2011) 
(Fig. 3). All the Kenyan CV-B3 isolates clustered closely 
with Indian strains isolated between 2008 and 2009 
(Fig. 4) while the CV-B4 generally appeared interspersed 
among sequences of homotypic strains that circulated in 
Europe, Asia and the United States of America (Fig.  5). 
The Kenyan EV-D68 isolates clustered together mostly 
with sequences of EV-D68 strains which circulated in the 
world between 2008 and 2010 (Fig. 6).      
Discussion
This paper outlines the diversity of HEV that circulated in 
the Kenyan pediatric population between 2008 and 2011. 
The multiplicity and frequency of the types reported were 
determined through homology and phylogenetic analyses 
of sequences of the partial VP1 region, relative to proto-
type strains. Overall, 22 different EV types belonging to 
Table 1 Comparison of  the partial VP1 sequences of  EV 
types detected in  Kenya with  those of  homotypic proto-
types
EV type (n) Sequence identities to homotypic EV 
prototype strains
% Nucleotide % Amino acid
CV-A4 (1) 85.39 100
CV-A8 (1) 88.52 98.02
CV-A10 (1) 75.03 92.16
EV-D71 (1) 97.75 99.03
CV-A9 (1) 90.32 96.43
EV-D75 (2) 85.71–87.1 96.09–98.32
CV-B1 (9) 77.03–80.92 95.12
CV-B2 (10) 81.36–83.18 96.47–97.65
CV-B3 (4) 75.2–77.56 90.12–92.59
CV-B4 (6) 78.34–82.95 92.86–100
CV-B5 (1) 85.51 93.98
CV-B6 (1) 75.35 93.98
E-3 (1) 75.45 90.48
E-6 (1) 80.65 95.24
E-11 (1) 74.02 89.29
E-14 (1) 79.55 92.94
E-19 (1) 79.82 98.31
E-20 (2) 80.65–82.49 94.05–95.24
E-21 (1) 90.91 96.47
E-25 (1) 81.57 95.24
E-30 (1) 79.09 91.76
EV-D68 (13) 85.94–87.5 84.89–90.48
Page 5 of 12Opanda et al. SpringerPlus  (2016) 5:158 
three of the seven known HEV species were identified. 
The bulk (72.0 %) of the types belonged to Enterovirus B 
species. This corroborates findings of Enterovirus diver-
sity from elsewhere (Harvala et al. 2014; Tan et al. 2011; 
Trallero et al. 2010; Bessaud et al. 2012). 21.3 % belonged 
to Enterovirus D species while 6.5 % were Enterovirus A. 
None of the types belonged to Enterovirus C. None to 
low detection levels (ranging from 0.0 to <5.0 %) of mem-
bers of Enterovirus C species is not peculiar to Kenya but 
have been reported elsewhere (Khetsuriani et  al. 2006; 
Tan et al. 2011; Bahri et al. 2005; Roth et al. 2007; Tseng 
et  al. 2007). The high detection levels of Enterovirus B 
Fig. 1 Bayesian phylogenetic tree based on nucleotide sequences of the 3′-end of the VP1 capsid region of human enterovirus strains. The tree 
was estimated using MrBayes 3.2 with a general time-reversible (GTR) substitution model. Posterior probabilities support values are shown on each 
node. The scale bar indicates number of nucleotide substitutions per site. EV-A Enterovirus A, EV-B Enterovirus B, EV-C Enterovirus C s, EV-D Enterovi-
rus D species. Kenyan strains are designated starting with HEV. The out-group is rhinovirus
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types is attributed to replication efficiency these viruses 
have in cell culture compared to those of Enterovirus A 
and Enterovirus C species and other numbered EV types 
(Tan et  al. 2011; Bryden 1992; Heim 2005; Kargar et  al. 
2009; Schmidt et al. 1975). Primers specific to enterovirus 
VP1 gene may fail to amplify some members of Entero-
virus A and D species (Nasri et al. 2007). Moreover, the 
absence of EV-C and low detection levels of EV-A viruses 
may be attributed to the use of only one cell line (RD cell 
line) during the isolation process (Rakoto-Andrianarivelo 
et  al. 2005). The failure of some samples to amplify by 
RT-PCR and sequence properly may be attributed to 
mixed enterovirus types (Oberste et  al. 2006; Apostol 
et  al. 2012) in the culture supernatants or other mem-
bers of Enterovirus genus such as Rhinovirus species. 
Indeed, preliminary BLASTn search analyses in this work 
showed that 28.2 % of the readable sequences generated 
were Rhinoviruses. Besides, the pan-enterovirus primers 
(292/222) used here are only able to amplify some mem-
bers of Rhinovirus species (Oberste and Pallansch 2003).
Fig. 2 Phylogenetic analysis based on nucleotide sequences of the 3′-end of the VP1 gene of CV-B1 strains. The tree was generated by MEGA 6.0 
using the neighbor-joining method. The filled triangles indicate the strains obtained in this study
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The most frequently detected type strains were Enter-
ovirus-D68 followed by Coxsackievirus B2 (CV-B2), 
CV-B1, CV-B4, and CV-B3. Notably, enterovirus-D68 
was the only species-D type detected in this study. This 
was not surprising as reports of increased worldwide cir-
culation of enterovirus-D68 viruses in recent times have 
been published (Imamura et  al. 2011; Kaida et  al. 2011; 
Rahamat-Langendoen et  al. 2011; Tokarz et  al. 2012; 
Opanda et  al. 2014). Enterovirus-68 has primarily been 
associated with respiratory disease (Imamura et al. 2011; 
Tokarz et  al. 2012; Hasegawa et  al. 2011; Meijer et  al. 
2012; Piralla et  al. 2014). Besides, enterovirus-B viruses 
are a significant cause of infections in children (Kumar 
et  al. 2013). CV-B1, CV-B2, CV-B3 and CV-B4 type 
strains have been frequently implicated with outbreaks 
of aseptic meningitis in young infants (Khetsuriani et al. 
2006; Tao et al. 2012; Wong et al. 2011; Verma et al. 2009; 
Wikswo et  al. 2009; Rezig et  al. 2004). The enterovirus 
A types detected in this work (i.e. EV-A71, CV-A8 and 
CV-A10) have more frequently been associated with spo-
radic outbreaks of hand, foot and mouth disease (Tan 
et  al. 2011; Zhu et  al. 2013; Chen et  al. 2016; Lu et  al. 
Fig. 3 Phylogenetic analysis of CV-B2 strains. Nucleotide sequences of the 3′-end of the VP1 gene were analyzed by the neighbor-joining methods 
and the tree generated by MEGA 6.0. The filled triangles indicate the strains obtained in this study
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2012). The Kenyan Echovirus 11 isolate appeared to be 
genetically different from the prototype strain (Gregory) 
but closely similar to sequences of contemporaneous 
E-11 strains isolated in Azerbaijan (2006) and Philippines 
(2009), suggesting evolutionary divergence from the 
prototype strain. Phylogenetic relationships of the most 
frequently detected EV types showed that the Kenyan 
CV-B1 isolates were genetically different from the global 
strains. CV-B2, CV-B3, CV-B4 and EV-D68 isolates were 
generally closely related to other strains detected from 
different countries, suggesting worldwide circulation of 
these viruses. The clustering of the Kenyan EV-D68 iso-
lates mostly with sequences of global strains obtained 
in other countries between 2008 and 2010 in contrast to 
those isolated in recent years may be attributed to high 
genomic variability associated with RNA viruses, includ-
ing enteroviruses (Apostol et  al. 2012; Holland et  al. 
1982).
Fig. 4 Phylogenetic relationships of CV-B3 strains. The tree was constructed by MEGA 6.0 based on nucleotide sequences of the 3′-end of the VP1 
gene, using the neighbor-joining method. The filled triangles indicate the stains obtained in this study
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Majority of the patients from whom the viruses were 
detected presented with symptoms associated with mild 
respiratory illnesses such as cough (100.0  %) and runny 
nose (91.8  %). Other clinical manifestations were also 
recorded. However clinical diagnoses were not provided 
by the Clinicians owing to study design. The sex ratio of 
the patients was 1.4:1 for male (57.4 %) to female (42.6 %). 
This mirrors findings from previous studies (Tao et  al. 
2014), plausibly suggesting higher exposure of male chil-
dren to enterovirus infection compared to female.
This work had some drawbacks. Being a retrospective 
study relying on isolates, some enteroviruses may have 
failed to grow in culture due to loss of viability during stor-
age. In addition, culture of these viruses in one type of cell 
line may have led to selective growth of some types and 
not others. These two shortcomings may have introduced 
bias in the diversity of EV types reported. Furthermore, 
the lone utilization of the partial VP1 region to detect the 
viruses may have led to non-detection of some enterovi-
ruses (Perera et al. 2010; Oberste et al. 2006). Despite these 
Fig. 5 Phylogenetic analysis of CV-B4 strains, based on nucleotide sequences of the 3′-end of the VP1 gene. The tree was constructed by using 
MEGA 6.0, using the neighbor-joining method. The filled triangles indicate the strains obtained in this study
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limitations, we have demonstrated circulation and consid-
erable diversity of enterovirus strains within the Kenyan 
pediatric population between 2008 and 2011. In future, full 
genome studies will augment our findings.
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